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Over the past 20 years chronic obstructive pulmonary disease (COPD) has become an“equal opportunity” disease with a greater number of women developing COPD and
suffering COPD-related morbidity and mortality around the world.1–5 Similarly, lung
cancer has also affected an increasing number of women,6 with lung cancer mortality now
high than breast cancer mortality among U.S. women.7 By 1999, 4.6% of deaths among
women and 5.1% of deaths among men were from COPD and 5.0% of deaths among
women and 7.6% of deaths among men were from lung cancer.6
These two highly prevalent diseases, both of which have cigarette smoking as a
strong risk factor, are also linked to each other. This linkage has been established in
different cohorts, although the reasons for this association remain unclear.8–10 In addition,
there is some evidence that this association is weaker in women compared with men.11,12
A recent review by Ben Zaken-Cohen et al.13 in explored gender-related differences
in the development of COPD and lung cancer and in the metabolism of tobacco smoke
constituents. They showed that certain cytochrome P450 enzymes, CYP1A1, CYP1A2,
and CYP3A4 have increased expression in women and suggest that these differences may
lead to gender-related differences in susceptibility to tobacco smoke (and presumably
other smoke) toxins. They further suggested that these differences in enzyme expression
may result in differential risk of lung cancer development.
In this issue of the Journal Schwartz et al. present data from a case-control study of
562 women with non-small cell lung cancer to 564 control women.14 Overall, 31.1% of
women in the case group reported COPD (defined as a diagnosis of chronic bronchitis,
COPD or emphysema), compared with 14.4% of controls. They found an increased risk
of lung cancer associated with a history of COPD among white women (Odds ratio 1.85,
95% confidence interval 1.21–1.81), but not among black women.
This article differs from previous recent analyses that have examined the relation
between COPD and lung cancer in that in this article the COPD was defined based on a
clinical diagnosis whereas in other articles COPD was defined on the basis of impaired
lung function.8,10,12 This is an important distinction in COPD is, in general, underdiag-
nosed1 and women are even more underdiagnosed, relative to men.15 Thus, the 31.1%
clinical diagnosis of COPD in the current study is lower than the 52.5% for women and
72.8% for men (based on lung function measurement) in a study of 294 lung cancer
patients by Loganathan et al.12
Another interesting finding in the analysis by Schwartz et al. was that the risk
between COPD and lung cancer was not seen in never smokers (Odds ratio 0.34, 95%
confidence interval 0.08–1.51). Although COPD occurs in never smokers4,16 it is likely
that the risks factors for and outcomes related to COPD in never smokers are very
different to that seen in current and former smokers.
This study provides additional evidence linking the presence of COPD to lung
cancer in women. The study suggests that this linkage may vary by race and age. Both
COPD and lung cancer are important diseases among both men and women. Under-
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standing more about how these diseases are related and
how that relation varies by sex, race, age, and smoking
status will, hopefully, lead to better prevention strategies
and interventions.
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